| Recent advances in glyoxalase-I inhibition QA Al-Balas, MA Hassan, NA Al-Shar'i, GA Al Jabal, AM Almaaytah Mini Reviews in Medicinal Chemistry 19 (4), 281-291, 2019 | 27 | 2019 |
| 14-3-3σ and its modulators in cancer G Aljabal, BK Yap Pharmaceuticals 13 (12), 441, 2020 | 25 | 2020 |
| Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents MA Al-Sha'er, QA Al-Balas, MA Hassan, GA Al Jabal, AM Almaaytah Computational Biology and Chemistry 80, 102-110, 2019 | 25 | 2019 |
| Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold NA AL-SHAR’I, QA AL-BALAS, MA HASSAN, TM EL-ELIMAT, ... Acta Pharmaceutica 71 (1), 115-130, 2020 | 23 | 2020 |
| Novel thiazole carboxylic acid derivatives possessing a “zinc binding feature” as potential human glyoxalase-I inhibitors Q A Al-Balasa, M A Hassana, G A Al Jabala, N A Al-Shar, A M Almaaytahb, ... Letters in Drug Design & Discovery 14 (11), 1324-1334, 2017 | 18 | 2017 |
| Multi-armed 1, 2, 3-selenadiazole and 1, 2, 3-thiadiazole benzene derivatives as novel glyoxalase-I inhibitors QA Al-Balas, ML Al-Smadi, MA Hassan, GA Al Jabal, AM Almaaytah, ... Molecules 24 (18), 3210, 2019 | 12 | 2019 |
| In Silico Molecular Docking Studies of Medicinal Arabic Plant-Based Bioactive Compounds as a Promising Drug Candidate against COVID-19 DF Alsaffar, A yaseen, GA Al Jabal | 10 | 2020 |
| Design, synthesis and biological evaluation of potential novel zinc binders targeting human glyoxalase-I; A validated target for cancer treatment Q Al-Balas, N Al-Shar'i, K Banisalman, M Hassan, G Al Jabal, ... Jordan Journal of Pharmaceutical Sciences 11 (1), 2018 | 8 | 2018 |
| Molecular docking and dynamic studies of a potential therapeutic target inhibiting glyoxalase system: Metabolic action of the 3, 3'-[3-(5-chloro-2-hydroxyphenyl)-3-oxopropane-1 … N Taïbi, QA Al-Balas, N Bekari, O Talhi, GA Al Jabal, Y Benali, ... Chemico-Biological Interactions 345, 109511, 2021 | 6 | 2021 |
| Development of analytical methods GC-MS vs LC-UV for the serum monitoring of an inflammatory glycotoxin (methylglyoxal): A new biomarker of bovine hepatobiliary distomatosis N Taïbi, A Taïbi, R Ameraoui, M Abou-Mustapha, M Hadjadj, ZM Boutaiba, ... Biochimie 168, 169-184, 2020 | 5 | 2020 |
| In silico studies on GCP-Lys-OMe as a potential 14-3-3σ homodimer stabilizer G Aljabal, BK Yap Pharmaceuticals 15 (10), 1290, 2022 | 2 | 2022 |
| Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking … MB Alhawarri, MG Al-Thiabat, A Dubey, A Tufail, K Banisalman, ... PloS one 20 (1), e0313094, 2025 | | 2025 |
| In Silico and Biophysical Techniques in Anticancer Drug Discovery Research A Ghazi, BK Yap | | 2024 |
| In Silico Prediction and Biophysical Validation of Novel 14-3-3σ Homodimer Stabilizers G Aljabal, T Aik-Hong, Y and Beow Keat Journal of Chemical Information and Modeling 63 (17), 5619–5630, 2023 | | 2023 |
| Population Prevalence of Asthma in Aljiza District MS Khalil Altaif, Nahla Aqel, Ghazi A. Al Jabal Indian Journal of Forensic Medicine & Toxicology 14, 2020 | | 2020 |
| Potential MAO‐B Inhibitors from Cissampelos Capensis L.f.: ADMET, Molecular Docking, Dynamics, and DFT Insights MG Al‐Thiabat, M Agrawal, K Kumar Sahu, MB Alhawarri, K Banisalman, ... Chemistry & Biodiversity, e202402351, 0 | | |
